Oscar Health, Inc. Issues Regulation FD Disclosure: Key Investor Insights
Summary of the 8-K Filing
On June 8, 2026, Oscar Health, Inc. (“Oscar Health” or the “Company”) filed a Form 8-K providing a Regulation FD Disclosure related to its participation at the Goldman Sachs 47th Annual Global Healthcare Conference. This update contains several points of direct relevance to shareholders and potential investors.
Key Points from the Report
- Conference Participation: Oscar Health will participate in a fireside chat at the Goldman Sachs 47th Annual Global Healthcare Conference on June 8, 2026, at approximately 11:20 AM ET.
- Business Update and Guidance Reaffirmation: At the conference, the Company plans to provide a business update and will reaffirm its full year 2026 guidance, as previously provided in the financial results press release dated February 10, 2026.
- Webcast Access: A live audio webcast of the presentation will be accessible via the Investor Relations page of Oscar Health’s website (ir.hioscar.com). A replay will also be available for approximately 90 days following the event.
- Nature of Disclosure: The Company reiterates that this information is being furnished pursuant to Regulation FD and is not considered “filed” under Section 18 of the Securities Exchange Act of 1934, nor is it incorporated by reference into any filings under the Securities Act of 1933 or the Exchange Act.
- Forward-Looking Statements: The filing contains forward-looking statements, especially regarding expected financial performance and upcoming events. The Company cautions investors not to place undue reliance on these statements, as they are subject to risks and uncertainties, and actual results could differ materially.
- Risk Factors Reference: Investors are directed to review the “Risk Factors” section in Oscar Health’s Annual Report on Form 10-K for the year ended December 31, 2025, and the Quarterly Report on Form 10-Q for the quarter ended March 31, 2026, for a comprehensive discussion of risks.
- Signatory: The filing was signed by R. Scott Blackley, Chief Financial Officer, on behalf of Oscar Health, Inc.
Important Considerations for Shareholders
- Reaffirmation of 2026 Guidance: The Company’s decision to publicly reaffirm its full-year 2026 guidance is significant. By confirming prior expectations, Oscar Health is signaling confidence in its business trajectory and outlook, which may be viewed positively by the market and could potentially influence share price.
- Upcoming Public Presentation: The fireside chat at a major healthcare conference (Goldman Sachs) places Oscar Health in front of a large institutional investor audience. These events can sometimes lead to market-moving disclosures or shifts in investor sentiment.
- Forward-Looking Statements and Risks: Investors should be mindful of the cautionary note regarding forward-looking statements. The Company acknowledges the presence of material risks and uncertainties, and actual performance may differ from current guidance.
- No New Material Developments Announced: Aside from reaffirming guidance and announcing participation at the conference, the Company has not disclosed any new material events, mergers, acquisitions, or changes in strategy in this filing.
Additional Corporate and Security Information
- Company Name: Oscar Health, Inc.
- Incorporated in: Delaware (DE)
- Business Address: 75 Varick Street, 5th Floor, New York, NY 10013
- Telephone: (646) 403-3677
- SEC File Number: 001-40154
- Trading Symbol: OSCR
- Exchange: New York Stock Exchange (NYSE)
- Class of Security: Class A Common Stock, \$0.00001 par value per share
- Emerging Growth Company Status: Oscar Health is not classified as an emerging growth company as of this filing.
Potential Market Impact
The reaffirmation of guidance and public presence at a leading healthcare investor conference are both supportive signals for Oscar Health shareholders. While there are no new surprises or material corporate actions disclosed, maintaining confidence in full-year expectations can help stabilize or positively influence investor sentiment, particularly if there have been recent market uncertainties.
Investors should monitor the upcoming presentation for any unscripted commentary or Q&A that could provide additional color on future performance, as such events sometimes reveal new information not present in formal filings.
Disclaimer: This article is a detailed summary and analysis based on Oscar Health, Inc.’s Form 8-K filed on June 8, 2026. It is intended for informational purposes only and does not constitute investment advice or a recommendation to buy or sell securities. Investors are encouraged to review the original SEC filings and consult with their financial advisors before making investment decisions. Forward-looking statements are subject to significant risks and uncertainties, and actual results may differ materially from those anticipated.
